Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma
Abstract
Aim: To demonstrate the efficacy of pomalidomide for relapsed/refractory multiple myeloma (RRMM) following treatment in real-world, community practice using retrospective database analysis. Materials & methods: US-based community oncologists identified patients with RRMM treated with or without pomalidomide following first-line lenalidomide. Disease response (≥ very good partial response) and progression-free survival were compared. Results:...
Paper Details
Title
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma
Published Date
Feb 1, 2022
Journal
Volume
18
Issue
5
Pages
553 - 564
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History